Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate as initial treatment in postpartum hemorrhage
2009-017736-41Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Fibrinogen human in postpartum hemorrhage (PPH), sponsored by Herlev Hospital. Primary endpoint: Allogeneic blood transfusion requirement. Started Feb 2010; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on 2009-017736-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017736-41.